Jul 21, 2022 / NTS GMT
Unidentified Participant
Thank you for standing by, and welcome to the Paradigm Biopharmaceuticals investor webinar, today. All participants are in a listen-only mode. There will be an initial slide presentation lasting approximately 40 minutes before we allow some time to get through as much Q&A as possible. (Operator Instructions) [If you are here] on behalf of Paradigm today, we have Chairman, Paul Rennie; CEO, Marco Polizzi; Chief Medical Officer, Dr. Donna Skerrett; and Director of Investor Relations, Simon White. To begin, I'll hand it over to Simon. Please go ahead.
Simon White - Paradigm Biopharmaceuticals Ltd. - Director of Investor Relations
Thanks, Matt. And a big welcome and thank you to everyone who has dialed into today's investor update. Today's webinar is an opportunity for Paradigm to introduce a new CEO, Marco Polizzi, who officially joins the company on July 1. Marco will provide some detail on his background in the industry and what excites him with the opportunity in front of us at Paradigm. We will then hear from Dr. Donna Skerrett on the progress
Paradigm Biopharmaceuticals Ltd Investor Webinar Transcript
Jul 21, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers